NewsDesk @bactiman63 Pfizer Inc. and Valneva SE announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524), to investigate the efficacy,...

NewsDesk @bactiman63 The Finland National Institute for Health and Welfare (THL) recommends that municipalities provide a fourth dose of coronavirus vaccine to those over 80 years of age and to all seniors...

NewsDesk @bactiman63 On Friday, Valneva and Pfizer reported further positive Phase 2 data for their Lyme disease vaccine candidate, VLA15. Based on these new results, Valneva and Pfizer plan to proceed...

NewsDesk  @infectiousdiseasenews Pfizer Inc. and BioNTech SE today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention...

NewsDesk  @infectiousdiseasenews Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster...

By NewsDesk  @infectiousdiseasenews On Friday morning, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines...

By NewsDesk  @bactiman63 The Costa Rica Ministry of Health said as of Monday, October 25, vaccination against COVID-19 will be opened for minors between 12 and 17 years old, throughout the country, as...

By NewsDesk  @bactiman63 In a follow-up on a post from earlier this month, the Swedish Public Health Agency has decided to continue to recommend Pfizer / Biontech’s COVID-19 vaccine, Comirnaty,...

By NewsDesk  @bactiman63 Philippines health officials reported an additional 633 cases of the COVID-19 Delta variant across the country today. A total of 748 samples were collected, of which more than...

By NewsDesk  @infectiousdiseasenews Finland’s National Institute for Health and Welfare (THL) instructed municipalities to provide only Biontech-Pfizer’s Comirnaty coronavirus vaccine to men...